Contract Service Directory

Par Sterile Products, LLC





Company Headquarters

One Upper Pond Road
Parsippany, NJ 07054
United States

Contract Service Directory

    Content From Par Sterile Products, LLC

    Related Content

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • Biologics, Proteins, Vaccines | Drug Development | Information Technology | R&D
      Cell Therapy Industry Update: What to Expect Near-Term

      Cell Therapy Industry Update: What to Expect Near-Term

      Martin Lamb of TrakCel discusses the key players, challenges, and advances in the cell therapy industry
      Kristin Brooks, Contract Pharma 07.10.17

    • Bio News | Breaking News | cGMP Manufacture | Industry News
      Sun Pharma & Samsung BioLogics Ink Mfg. Deal

      Sun Pharma & Samsung BioLogics Ink Mfg. Deal

      Enter $50 million strategic manufacturing tie-up for Tildrakizumab
      07.05.17


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Selexis Teams Up With Takeda

      Selexis Teams Up With Takeda

      Forms commercial license agreement for the development of fusion proteins
      06.28.17

    • Bio News | Industry News | Solid Dosage/Semi-solids | Supply Chain
      TruTag to Showcase On-Dose Authentication at BIO

      TruTag to Showcase On-Dose Authentication at BIO

      High-security solution designed to provide absolute certainty of a product’s identity
      06.16.17

    • Breaking News | Drug Delivery | Industry News | Inspections
      Tapemark Passes Regulatory Hurdle

      Tapemark Passes Regulatory Hurdle

      Manufacturing facility completes successful FDA pre-approval and general GMP inspection
      06.07.17


    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?
      06.06.17

    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported
      06.05.17

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17


    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Avista to Support Development of an Opioid Addiction Vaccine

      Avista to Support Development of an Opioid Addiction Vaccine

      Mfg. and dev. partnership with Minneapolis Medical Research Foundation to produce conjugate vaccine to combat substance abuse
      05.26.17

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis SA and OSE Immunotherapeutics Enter Pact

      Selexis SA and OSE Immunotherapeutics Enter Pact

      Sign agreement for the development of OSE's interleukin receptor 7 antagonist
      05.24.17

    • Pharma Tech Industries Names New VP of Business Development

      Pharma Tech Industries Names New VP of Business Development

      The new vice president of business development at Pharma Tech Industries, Eric Kaneps.


    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17

    • Trump Picks New FDA Commish

      Combatting high drug prices and overregulation likely to be high on agenda
      Tim Wright, Editor 04.03.17

    • Promotions & Moves

      Worldwide Clinical Trials Names EVP of Global BD

      Hirschman to lead business development organization
      03.30.17

    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Promotions & Moves

      AB BioTechnologies Adds BD Director

      Ladd brings more than 17 years of industry experience
      03.07.17

    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization

      LSNE Completes Two FDA Inspections

      FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully
      03.06.17


    • QA/QC | Regulatory Affairs
      FDA’s Quality Agreements Guidance

      FDA’s Quality Agreements Guidance

      Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
      Paul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17